References
- The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShopOcul Surf20075759217508116
- GalorAFeuerWLeeDJDepression, post-traumatic stress disorder, and dry eye syndrome: a study utilizing the national United States Veterans Affairs administrative databaseAm J Ophthalmol2012154340.e23466.e222541654
- SchaumbergDADanaRBuringJESullivanDAPrevalence of dry eye disease among US men: estimates from the Physicians’ Health StudiesArch Ophthalmol200912776376819506195
- SchaumbergDASullivanDABuringJEDanaMRPrevalence of dry eye syndrome among US womenAm J Ophthalmol200313631832612888056
- ShehaHTsengSCGThe role of amniotic membrane for managing dry eye diseaseOcular Surface Disorder39th edLondonJP Medical2013325329
- ChengAMZhaoDChenRAccelerated restoration of ocular surface health in dry eye disease by self-retained cryopreserved amniotic membraneOcul Surf201614566326387870
- JohnTTigheSShehaHCorneal nerve regeneration after self-retained amniotic membrane in dry eye diseaseJ Ophthalmol2017640491828894606
- LambiaseASacchettiMBoniniSNerve growth factor therapy for corneal diseaseCurr Opin Ophthalmol20122329630222543481
- JainPLiRLamaTSaragoviHUCumberlidgeGMeerovitchKAn NGF mimetic, MIM-D3, stimulates conjunctival cell glycoconjugate secretion and demonstrates therapeutic efficacy in a rat model of dry eyeExp Eye Res20119350351221726552
- LabbeALiangQWangZCorneal nerve structure and function in patients with non-Sjogren dry eye: clinical correlationsInvest Ophthalmol Vis Sci2013545144515023833066
- TouhamiAGrueterichMTsengSCThe role of NGF signaling in human limbal epithelium expanded by amniotic membrane cultureInvest Ophthalmol Vis Sci20024398799411923238
- BanerjeeANurnbergerSHennerbichlerSIn toto differentiation of human amniotic membrane towards the Schwann cell lineageCell Tissue Bank20141522723924166477
- AloeLTirassaPLambiaseAThe topical application of nerve growth factor as a pharmacological tool for human corneal and skin ulcersPharmacol Res20085725325818329283
- MaychukDYPrevalence and severity of dry eye in candidates for laser in situ keratomileusis for myopia in RussiaJ Cataract Refract Surg20164242743427063524
- WeiYAsbellPAThe core mechanism of dry eye disease is inflammationEye Contact Lens20144024825625390549
- YagciAGurdalCThe role and treatment of inflammation in dry eye diseaseInt Ophthalmol2014341291130125416345
- ParkWCTsengSCGModulation of acute inflammation and keratocyte death by suturing, blood and amniotic membrane in PRKInvest Ophthalmol Vis Sci2000412906291410967044
- WangMXGrayTBParksWCCorneal haze and apoptosis is reduced by amniotic membrane matrix in excimer laser photoablation in rabbitsJ Cat Refract Surg200127310319
- ShimmuraSShimazakiJOhashiYTsubotaKAntiinflammatory effects of amniotic membrane transplantation in ocular surface disordersCornea20012040841311333331
- BauerDWasmuthSHermansPOn the influence of neutrophils in corneas with necrotizing HSV-1 keratitis following amniotic membrane transplantationExp Eye Res20078533534517637463
- HeiligenhausABauerDMellerDSteuhlKPTsengSCImprovement of HSV-1 necrotizing keratitis with amniotic membrane transplantationInvest Ophthalmol Vis Sci2001421969197411481259
- BauerDWasmuthSHennigMBaehlerHSteuhlKPHeiligenhausAAmniotic membrane transplantation induces apoptosis in T lymphocytes in murine corneas with experimental herpetic stromal keratitisInvest Ophthalmol Vis Sci2009503188319819255156
- BauerDHennigMWasmuthSAmniotic membrane induces peroxisome proliferator-activated receptor-gamma positive alternatively activated macrophagesInvest Ophthalmol Vis Sci20125379981022222510
- LiWHeHKawakitaTEspanaEMTsengSCGAmniotic membrane induces apoptosis of interferon-gamma-activated macrophages in vitroExp Eye Res20068228229216109408
- HeHLiWChenSYSuppression of activation and induction of apoptosis in RAW264.7 cells by amniotic membrane extractInvest Ophthalmol Vis Sci2008494468447518614802
- MorkinMIHamrahPEfficacy of self-retained cryopreserved amniotic membrane for treatment of neuropathic corneal painOcul Surf201816113213829032001
- LambiaseAMantelliFSacchettiMRossiSAloeLBoniniSClinical applications of NGF in ocular diseasesArch Ital Biol201114928329221702001
- NamavariAChaudharySChangJHCyclosporine immunomodulation retards regeneration of surgically transected corneal nervesInvest Ophthalmol Vis Sci20125373274022205605
- LeeHKRyuIHSeoKYHongSKimHCKimEKTopical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patientsOphthalmology200611319820516360211
- GaynesBIOnyekwulujeATopical ophthalmic NSAIDs: a discussion with focus on nepafenac ophthalmic suspensionClin Ophthalmol2008235536819668727
- SuriKKoskerMRaberIMSutureless amniotic membrane prokera for ocular surface disorders: short-term resultsEye Contact Lens20133934134723945524
- BrewittHSistaniFDry eye disease: the scale of the problemSurv Ophthalmol200145Suppl 2S199S20211587143
- The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShopOcul Surf200759310717508117